9G3-17649-19015
4 vaccinations
8 coded responses
32 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 871 / NM
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-03
Dose 1 — Moderna
-
2021-02-04
Registered in v-safe
-
2021-02-04
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, SwellingFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
-
2021-02-10
Health check-in — day 7, dose 1Feeling: Fair · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-17
Survey response — day 14, dose 1MedDRA: Injection site urticaria, Peripheral swelling, Pruritus — Feeling: GoodFree text: Severe erythema extending length of entire deltoid. Moderate swelling of deltoid. Severe itching over area. Small wheel at actual injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
-
2021-03-03
Dose 2 — Moderna
-
2021-03-17
Survey response — day 14, dose 2MedDRA: Asthenia, Fatigue, Headache, Nausea, Pain, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mild fever, fatigue, body aches, weakness, nausea, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-06-02
- 2021-09-01
-
2021-12-29
Dose 3 — Moderna
-
2022-03-03
Survey response — 12 months, dose 2MedDRA: Cough, SARS-CoV-2 test negative — Feeling: GoodFree text: Chronic cough after negative antigen covid test (PCR not run)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Dose 4 — Pfizer-BioNTech
- 2022-11-08
-
2022-11-09
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-11-10
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Rash, not including the immediate area around the injection siteFree text: Severe lymphadenopathy of supraclavicular and axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Moderate to severe lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-12
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Site: Swelling · Headache · Be unable to do your normal daily activitiesFree text: Moderate lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-13
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · HeadacheFree text: Mild lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2022-11-14
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2022-12-06
- 2022-12-13
- 2022-12-20
- 2023-02-07
- 2023-05-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Moderna | |
| 2 | 2021-03-03 | Moderna | |
| 3 | 2021-12-29 | Moderna | No |
| 4 | 2022-11-08 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness
Release 4 — day 14, dose 1
Symptoms: Severe erythema extending length of entire deltoid. Moderate swelling of deltoid. Severe itching over area. Small wheel at actual injection site.
Release 5 — day 14, dose 2
Symptoms: Mild fever, fatigue, body aches, weakness, nausea, headache
Release 11 — 12 months, dose 2
Symptoms: Chronic cough after negative antigen covid test (PCR not run)
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Severe lymphadenopathy of supraclavicular and axillary lymph nodes
Systemic reaction (other): Moderate to severe lymphadenopathy
Systemic reaction (other): Moderate lymphadenopathy
Systemic reaction (other): Mild lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site urticaria | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release